MedTrace Logo

Visual Outcomes and Patient Satisfaction After Bilateral Implantation of Non-diffractive EDOF IOL Made of a New Hydrophobic Acrylic Material

NCT05488769 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2023-01-19

No results posted yet for this study

Summary

The objective is to measure the range of vision and patient reported visual disturbances after bilateral implantation for this unique non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) made from the Clareon material.

Conditions

  • Cataract

Interventions

DEVICE

Clareon Vivity extended depth of focus (EDOF) intraocular lens

Implantation with the Clareon Vivity extended depth of focus (EDOF) intraocular lens

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Thomas Nagy

    lead OTHER

Principal Investigators

  • Thomas Nagy, MD · Vision North Eye Centre

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-25
Primary Completion
2022-11-29
Completion
2022-11-29
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05488769 on ClinicalTrials.gov